Intuitive Surgical Inc. Files Definitive Proxy Statement

Ticker: ISRG · Form: DEF 14A · Filed: Mar 8, 2024 · CIK: 1035267

Sentiment: neutral

Topics: Proxy Statement, DEF 14A, Intuitive Surgical, Corporate Governance, Shareholder Meeting

TL;DR

<b>Intuitive Surgical Inc. has filed its definitive proxy statement for the fiscal year ending December 31, 2023.</b>

AI Summary

INTUITIVE SURGICAL INC (ISRG) filed a Proxy Statement (DEF 14A) with the SEC on March 8, 2024. Intuitive Surgical Inc. filed a Definitive Proxy Statement (DEF 14A) on March 8, 2024. The filing covers the fiscal year ending December 31, 2023. The company's principal executive offices are located at 1020 Kifer Road, Sunnyvale, CA 94086. The filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934. The SIC code for Intuitive Surgical Inc. is 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies).

Why It Matters

For investors and stakeholders tracking INTUITIVE SURGICAL INC, this filing contains several important signals. This filing is a standard requirement for publicly traded companies to provide shareholders with information regarding upcoming meetings, director nominations, executive compensation, and other corporate governance matters. Shareholders will use this document to make informed decisions when voting on proposals at the company's annual meeting.

Risk Assessment

Risk Level: low — INTUITIVE SURGICAL INC shows low risk based on this filing. The filing is a routine DEF 14A, indicating no immediate material changes or adverse events are being disclosed beyond standard corporate governance information.

Analyst Insight

Review the proxy statement for details on executive compensation, board nominations, and shareholder proposals to understand management's strategy and governance practices.

Key Numbers

Key Players & Entities

FAQ

When did INTUITIVE SURGICAL INC file this DEF 14A?

INTUITIVE SURGICAL INC filed this Proxy Statement (DEF 14A) with the SEC on March 8, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by INTUITIVE SURGICAL INC (ISRG).

Where can I read the original DEF 14A filing from INTUITIVE SURGICAL INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by INTUITIVE SURGICAL INC.

What are the key takeaways from INTUITIVE SURGICAL INC's DEF 14A?

INTUITIVE SURGICAL INC filed this DEF 14A on March 8, 2024. Key takeaways: Intuitive Surgical Inc. filed a Definitive Proxy Statement (DEF 14A) on March 8, 2024.. The filing covers the fiscal year ending December 31, 2023.. The company's principal executive offices are located at 1020 Kifer Road, Sunnyvale, CA 94086..

Is INTUITIVE SURGICAL INC a risky investment based on this filing?

Based on this DEF 14A, INTUITIVE SURGICAL INC presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating no immediate material changes or adverse events are being disclosed beyond standard corporate governance information.

What should investors do after reading INTUITIVE SURGICAL INC's DEF 14A?

Review the proxy statement for details on executive compensation, board nominations, and shareholder proposals to understand management's strategy and governance practices. The overall sentiment from this filing is neutral.

How does INTUITIVE SURGICAL INC compare to its industry peers?

Intuitive Surgical Inc. operates in the medical device industry, specifically in the field of robotic-assisted surgical systems.

Are there regulatory concerns for INTUITIVE SURGICAL INC?

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

Industry Context

Intuitive Surgical Inc. operates in the medical device industry, specifically in the field of robotic-assisted surgical systems.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Rule 14a-101, which governs the content of proxy statements.

What Investors Should Do

  1. Review executive compensation details for key executives.
  2. Examine director nominations and qualifications.
  3. Analyze any shareholder proposals and management's recommendations.

Key Dates

Year-Over-Year Comparison

This is the initial filing of the Definitive Proxy Statement for the fiscal year ending December 31, 2023. Previous filings would have covered prior fiscal years.

Filing Stats: 4,844 words · 19 min read · ~16 pages · Grade level 11 · Accepted 2024-03-08 16:10:47

Key Financial Figures

Filing Documents

Executive Compensation

Executive Compensation 31 Compensation Committee Report 31 Compensation Discussion and Analysis 32 Executive Summary 32

Executive Compensation Philosophy

Executive Compensation Philosophy 39 Compensation Risk Considerations 39 Compensation of Named Executive Officers 50 Pay versus Performance 59 Certain Relationships and Related Transactions 64

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 66 Audit Committee Report 69 Principal Accountant Fees and Services 70 Overview of Proposals 71 Proposal No. 1 - Election of Directors 72 Proposal No. 2 - Advisory Approval of the Compensation of the Named Executive Officers 73 Proposal No. 3 - Ratification of the Appointment of the Independent Registered Public Accounting Firm 74 Proposal No. 4 - Approval of the Amendment and Restatement of the Amended and Restated 2010 Incentive Award Plan 75 Proposal No. 5 - Approval of the Amendment and Restatement of the Amended and Restated 2000 Employee Stock Purchase Plan 85 Proposal No. 6 - Stockholder Proposal Requesting a Racial and Gender Pay Gap Report 89 Other Information 95 Non-GAAP Financial Measures 96 3 Table of Contents GENERAL INFORMATION Why am I receiving these materials? Our Board of Directors (our "Board") has made these materials available to you on the Internet or has delivered printed versions of these materials to you by mail in connection with the solicitation of proxies to be voted at our Annual Meeting of Stockholders (the "Annual Meeting") to be held on April 25, 2024, at 3:00 p.m., Pacific Daylight Time, at the location and for the purposes as set forth in the "Notice of the 2024 Annual Meeting of Stockholders." Our stockholders are invited to attend the Annual Meeting either in person or virtually online and are requested to vote on the proposals described in this Proxy Statement. The approximate date on which this Proxy Statement and form of proxy will be first made available to stockholders is March 12, 2024. What is included in these materials? These materials include: This Proxy Statement for the Annual Meeting. Our 2023 Annual Report to Stockholders, which includes our audited consolidated financial statements. If you received printed versions of these materials by mail, these materials also include the p

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing